| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |